39
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary.

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Major depressive disorder (MDD) is a significant public health concern and challenges health care providers to intervene with appropriate treatment. This article provides an overview of efficacy and safety information for duloxetine 60 mg/day in the treatment of MDD, including its effect on painful physical symptoms (PPS).

          Related collections

          Author and article information

          Journal
          Drugs Context
          Drugs in context
          BioExcel
          1745-1981
          1740-4398
          Jan 03 2013
          : 2013
          Affiliations
          [1 ] Lilly Research Laboratory, Eli Lilly and Company, Indianapolis, IN, USA;
          [2 ] Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA;
          [3 ] Lilly Research Centre, Windlesham, Surrey, UK; ; The Gordon Hospital, London, UK.
          Article
          dic_212245
          10.7573/dic.212245
          3884746
          24432034
          63da6ebc-ed39-4384-9fe9-c92c901ff42b
          History

          duloxetine,effect size,major depressive disorder,painful physical symptoms,quality of life,safety and tolerability

          Comments

          Comment on this article